Astrana Health (ASTH) Cash from Investing Activities (2010 - 2026)

Astrana Health has reported Cash from Investing Activities for 17 years, with the latest figure at -$2.8 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 18.8% year-over-year to -$2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$539.4 million (down 335.92% YoY) and the FY2025 annual result came in at -$539.0 million, down 180.15% from the prior year.
• Cash from Investing Activities slipped to -$2.8 million in Q1 2026 per ASTH's latest filing, from -$1.1 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $13.2 million in Q4 2022 and troughed at -$534.5 million in Q3 2025.
• A 5-year average of -$47.5 million and a median of -$8.1 million in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities jumped 171.44% in 2022, then plunged 6492.71% in 2025.
• Over 5 years, Cash from Investing Activities stood at $13.2 million in 2022, then slumped by 186.56% to -$11.4 million in 2023, then sank by 191.63% to -$33.3 million in 2024, then soared by 96.83% to -$1.1 million in 2025, then tumbled by 169.06% to -$2.8 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$2.8 million, -$1.1 million, and -$534.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.